Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | POLQ | O75417 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10069231 | 0.98 | GFER (0.38) | GFERPOLQIDO1KCNH2SCN10A | |
| SCHEMBL10038696 | 0.92 | POLQ (0.36) | GFERPOLQ | |
| SCHEMBL17933033 | 0.92 | CRHBP (0.35) | PTGDR2RORCCRHBPCRHR2 | |
| SCHEMBL10068685 | 0.92 | CRHBP (0.35) | PTGDR2RORCCRHBPCRHR2 | |
| SCHEMBL10038759 | 0.90 | POLQ (0.37) | GFERPOLQIDO1 | |
| SCHEMBL10069245 | 0.90 | POLQ (0.34) | GFERPOLQIDO1 | |
| SCHEMBL21870115 | 0.89 | THRB (0.34) | POLQ | |
| SCHEMBL10068832 | 0.87 | ALDH1A1 (0.33) | — | |
| SCHEMBL10068681 | 0.87 | KCNA5 (0.39) | RORC | |
| SCHEMBL10069131 | 0.87 | ALDH1A1 (0.42) | RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120013244-A1 | ORGANIC LUMINESCENT MEDIUM | IDEMITSU KOSAN CO., LTD. | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120013244-A1 | ORGANIC LUMINESCENT MEDIUM | ANXA1, ANXA11, GLB1 | GFER 1638/4885POLQ 3106/4885IDO1 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.